REQUEST A DEMO
Total
USD $0.00
Search more companies

Icls Biotehnologiya OOO (Russia)

Main Activities: Testing Laboratories
Full name: Icls Biotehnologiya OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Icls Biotehnologiya OOO is an enterprise in Russia, with the main office in Moscow. The enterprise operates in the Testing Laboratories industry. Icls Biotehnologiya OOO was incorporated on August 23, 2019. In 2023, the company reported a net sales revenue drop of 10.98%. Over the same period, its total assets decreased by 1.68%. The net profit margin of Icls Biotehnologiya OOO increased by 10.06% in 2023.

Headquarters
6-Ya Radialinaya, 24, 14
Moscow; Moscow; Postal Code: 115404

Contact Details: Purchase the Icls Biotehnologiya OOO report to view the information.

Website: http://biotechnologia.ru

Basic Information
Outstanding Shares:
Purchase the Icls Biotehnologiya OOO report to view the information.
Registered Capital:
Purchase the Icls Biotehnologiya OOO report to view the information.
Incorporation Date:
August 23, 2019
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Icls Biotehnologiya OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-10.98%
Total operating revenue
-10.98%
Operating profit (EBIT)
41.82%
Net Profit (Loss) for the Period
245.3%
Total assets
-1.68%
Total equity
2.69%
Operating Profit Margin (ROS)
4.35%
Net Profit Margin
10.06%
Return on Equity (ROE)
17.97%
Quick Ratio
-0%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?